Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog
posted on
Mar 17, 2013 07:51PM
Edit this title from the Fast Facts Section
Bob,
You are correct - my bad. It's been so long since I researched things for the original thread a couple months ago. As I recall now, I came to the conclusion that FIAsp was a new formulation of NovoRapid, but details were sparse. Thus I had posted the NovoRapid monologue back then - as a baseline. But honestly, I'm not holding my breath on a major improvement - just based on the kinetics of subcutaneous injection vs inhalation.